XML 24 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock [Member]
Additional Paid-in-Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income [Member]
Treasury Stock, Common
Treasury Stock, Common
Share Repurchase Program [Member]
Noncontrolling Interest
Balance (in shares) at Sep. 26, 2020   295,107       37,609    
Balance at Sep. 26, 2020 $ 2,707.3 $ 2.9 $ 5,904.8 $ (1,573.2) $ (49.7) $ (1,579.6)   $ 2.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of stock options (in shares)   857            
Stock Issued During Period, Value, Stock Options Exercised 32.9   32.9          
Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)   980            
Restricted Stock, Value, Shares Issued Net of Tax Withholdings (47.5)   (47.6)          
Common stock issued under the employee stock purchase plan (in shares)   362            
Stock Issued During Period, Value, Employee Stock Purchase Plan 18.9   18.9          
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 65.0   65.0          
Net income attributable to Hologic 1,871.5     1,871.5        
Repurchase of common stock (in shares)             6,044  
Treasury Stock, Value, Acquired, Par Value Method (409.8)           $ (409.8)  
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent (20.2)       (20.2)      
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 0.5       0.5      
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax 0.4       0.4      
Unrealized loss on interest rate swap 9.4       9.4      
Net income attributable to Hologic 1,869.7             (1.8)
Balance (in shares) at Sep. 25, 2021   297,306       43,653    
Balance at Sep. 25, 2021 4,218.6 $ 3.0 5,965.8 298.3 (59.1) $ (1,989.4)   0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Purchase of non-controlling interest reclassified to APIC     (8.2)          
Change in par value 0.1              
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax 0.5       0.5      
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests (8.5)             (0.3)
Exercise of stock options (in shares)   336            
Stock Issued During Period, Value, Stock Options Exercised 13.8   13.8          
Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)   561            
Restricted Stock, Value, Shares Issued Net of Tax Withholdings (22.9)   (22.9)          
Common stock issued under the employee stock purchase plan (in shares)   330            
Stock Issued During Period, Value, Employee Stock Purchase Plan 19.2   19.2          
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 66.7   66.7          
Net income attributable to Hologic 1,302.0     1,302.0        
Repurchase of common stock (in shares)             7,748  
Treasury Stock, Value, Acquired, Par Value Method (542.1)           $ (542.1)  
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent (224.1)       (224.1)      
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 1.0       1.0      
Unrealized loss on interest rate swap (44.0)       44.0      
Net income attributable to Hologic 1,302.0              
Balance (in shares) at Sep. 24, 2022   298,533       51,401    
Balance at Sep. 24, 2022 $ 4,876.2 $ 3.0 6,042.6 1,600.3 (238.2) $ (2,531.5)   0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of stock options (in shares) 500 504            
Stock Issued During Period, Value, Stock Options Exercised $ 21.5   21.5          
Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)   555            
Restricted Stock, Value, Shares Issued Net of Tax Withholdings (24.0)   (24.0)          
Common stock issued under the employee stock purchase plan (in shares)   348            
Stock Issued During Period, Value, Employee Stock Purchase Plan 21.5   21.5          
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 79.6   79.6          
Net income attributable to Hologic 456.0     456.0        
Repurchase of common stock (in shares)             6,830  
Treasury Stock, Value, Acquired, Par Value Method (504.5)           $ (504.5)  
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent 99.2       99.2      
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 0.6       0.6      
Unrealized loss on interest rate swap (9.2)       (9.2)      
Net income attributable to Hologic 456.0              
Balance (in shares) at Sep. 30, 2023   299,940       58,231    
Balance at Sep. 30, 2023 $ 5,016.9 $ 3.0 $ 6,141.2 $ 2,056.3 $ (147.6) $ (3,036.0)   $ 0.0